A study carried out by researchers based at the University of Cambridge (UK) and biotechnology company SomaLogic (CO, USA) has demonstrated that large-scale measurements of proteins in a single blood test could predict risk factors for a range of diseases.
Browsing: blood test
Researchers from the University of Texas Southwestern Medical Center (TX, USA) have identified a biomarker blood test that could identify individuals with early-stage heart disease in need of treatment.
Researchers have analyzed flotillin levels in samples from individuals with and without Alzheimer’s disease (AD) and determined that serum flotillin levels are negatively associated with brain amyloid deposition. Flotillin could serve as a biomarker to estimate brain amyloid deposition, potentially aiding the early diagnosis of AD.
Researchers have reported a new blood test that could accurately identify and distinguish active cases of tuberculosis in adults from diseases with similar symptoms in under 1 hour.
Researchers based at the University of Dundee (Scotland) have reported a serum based assay that could be capable of predicting disease severity and clinical outcome of abdominal aortic aneurysm.
A new microfluidics device has been developed that could detect individual cancer cells in blood and has the potential to be used for liquid biopsies.
A novel protein has been discovered that could be a useful blood-based biomarker to monitor the progression of inherited Alzheimer’s disease, over a decade before the clinical symptoms appear.
Researchers from the University of Queensland (Australia) have discovered a unique biomarker common to multiple cancers that has the potential to change the way early stage cancer is diagnosed.
Read more about the top stories in biomarker developments in this week’s news round-up.
Read time: 1 min
Novel blood and urine tests have been developed by a team of researchers from the University of Warwick (UK) to detect autism in children.